The evolving landscape of metabolic dysfunction-associated steatohepatitis (MASH) research demands precise and reliable methodologies to ensure accurate data collection and analysis. In this upcoming webinar, the expert speakers will provide a deep dive into the imaging and histological techniques that are foundational to metabolic dysfunction-associated steatohepatitis studies. Attendees will also gain insights into the operational and medical strategies that streamline the research process, ensuring that studies are conducted with the highest level of quality and consistency.
Learn from Medpace experts, as they explore strategies to enhance operational efficiency, focusing on ensuring seamless integration of data throughout the study process — from sample collection to final analysis. They will also cover best practices for the preparation and standardization of liver biopsy samples, essential for accurate histological evaluation. This will include detailed guidance on resolving connectivity issues related to transitioning from traditional microscopy to whole-slide digital images. Additionally, the webinar will discuss the evolution of read paradigms in histology, from single to multi-read techniques, and the implications this has for diagnostic accuracy and research outcomes in metabolic dysfunction-associated steatohepatitis.
This webinar will thus offer a comprehensive overview from sample acquisition of biopsy samples to final endpoint analysis — emphasizing the importance of maintaining consistency across tissue batches over extended study periods, which is crucial for the integrity of metabolic dysfunction-associated steatohepatitis studies. Register for this webinar today.
Speakers
Dr. Salvatore Zabbatino, MD, Senior Director, Core Laboratories, Medpace
Dr. Salvatore Zabbatino has over 30 years of experience in pharmaceutical and device clinical research. He has been a part of the Medpace leadership team since its founding in 1992, serving as Director in key departments. Dr. Zabbatino has held leadership roles across a number of areas, including clinical operations, regulatory, medical writing, biometrics/data management, IT, imaging and cardiovascular services.
He focuses on integrating and optimizing the clinical, operational and technical aspects needed to conduct multinational studies across multiple therapeutic indications. Dr. Zabbatino has extensive experience with imaging and other biomarkers of drug and device safety and efficacy in clinical trials, including DXA (BMD and TBC), Cardiac Echo, Cardiac SPECT, Ultrasound, MR, CT, endoscopy, photography, ECG, Holter and ABPM.
Message Presenter
Dr. Robert McGee, MD, PhD, Senior Medical Director, Central Laboratories, Medpace
Dr. Robert McGee is board-certified in both anatomic and clinical pathology and brings 25 years of combined experience in diagnostic and central laboratory anatomic pathology/histology to Medpace. He is an active committee member of the College of American Pathologists, with assignments to the histotechnology committee, digital and computational pathology committee and reproductive medicine committee.
Message Presenter
Dr. Nicola Owen, PhD, MBBS, Medical Director, Medpace
Dr. Nicola Owen is an accredited Gastroenterologist and Hepatologist, having attained board-equivalent certification (CCT) in gastroenterology, hepatology and internal medicine in 2021. She has 19 years of clinical experience with over 11 years of specialist experience in hepatology and gastroenterology. Prior to joining Medpace, Dr. Owen served as a Consultant Hepatologist at King’s College Hospital, a world-renowned specialist liver care center.
She was a Principal Investigator and Investigator in a diverse portfolio of clinical trials. As the lead of the Advanced Chronic Liver Disease Service, she managed patients with advanced liver disease of all etiologies, receiving complex referrals from across the United Kingdom.
Message Presenter
Jenson Ruiz Garcia, MSc, Clinical Trial Management, Medpace
Jenson Ruiz Garcia started his clinical research career at Medpace in 2018. Mr. Garcia has nine years of experience in managing Phase I-III trials, including a successful working relationship and collaboration with flagship sites and KOLs.
He has demonstrated a passion for research, risk-based management approach and leadership skills throughout his clinical career where he has led multiple large global outcome trials. He received a Master of Science in Molecular Biology of Infectious Disease from the London School of Hygiene and Tropical Medicine, London, UK.
Message PresenterWho Should Attend?
This webinar will appeal to VPs, Directors, Managers and department heads working within:
- Clinical development
- Clinical affairs
- Clinical research
- Clinical pharmacology
- Clinical outsourcing
- Clinical operations
- Regulatory affairs
- Medical affairs
What You Will Learn
Attendees will learn about:
- Operational efficiency in metabolic dysfunction-associated steatohepatitis studies by ensuring seamless integration of data from sample collection to analysis
- Imaging and histological techniques for metabolic dysfunction-associated steatohepatitis by preparing and standardizing liver biopsy samples
- The evolution of read paradigms from single to multi-read techniques
Xtalks Partner
Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account